Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
Anders Hove is Founder and Partner at Acorn Bioventures, a New York–based biotech investor deploying $100 K–$5 M across seed, crossover, and public-market financings. His most recent position is a reported stake in Candel Therapeutics, and he operates out of New York, New York. Dr. Hove earned an MD from the University of Copenhagen and an MBA from INSEAD, and he formerly served as a Managing General Partner at Venrock and portfolio manager at BB Biotech.
Previous investments
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Shaun Abrahamson
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Steve Brownlie
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free